Clinical Trial Update: Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BT086 as adjunctive therapy for community-acquired pneumonia has completed, reporting safety and efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• BT086

Snippet

Sponsor: Biotest | Conditions: Community Acquired Pneumonia | Phase 2 | Status: COMPLETED